Beryl Drugs Limited

₹25.70As of Sun 8 Nov 2026, 12:00 UTC
BSE:524606Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 3.70%
Div yield —
ROE 4.39%
Pharmaceutical Preparations
Beta (5Y) 0.12
PE TTM 20.87
TSR TTM 6.95%
Mkt cap ₹130.3M
ROIC 7.20%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹27
5.66%
(88.22%)
Buy 12|1|1|9|3
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.33
0.32
0.33
0.32
12.71%
(1.84%)
(1.88%)
(4.61%)
Revenue₹M
9.648
9.483
9.666
9.447
3.84%
(0.34%)
(3.28%)
(3.41%)
Peers (US$1.397M)
Cap (US$)
PE
1.314M
75.47x
Capital
TTM
5Y
10Y
Leveragex
2.320
(0.154)
(0.160)
EBIT/Intx
6.712
0.471
0.525
Own earn%
120.13
(43.27)
(39.93)
Sh yield%
39.28
27.12
26.32
Owners
Insiders/Inst%
3.36
65.43
Short interest%
0.53
SBC / revenue%
1.06
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
7–16
$1 testx
—
Incr. ROIC%
11